Microbot Medical (NASDAQ:MBOT) Shares Cross Above Two Hundred Day Moving Average – Should You Sell?

Microbot Medical Inc. (NASDAQ:MBOT) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.99 and traded as high as $1.03. Microbot Medical shares last traded at $1.01, with a volume of 189,160 shares.

Microbot Medical Trading Up 1.5 %

The stock has a market capitalization of $16.13 million, a PE ratio of -1.13 and a beta of 1.64. The stock’s fifty day simple moving average is $0.94 and its 200-day simple moving average is $0.99.

Microbot Medical (NASDAQ:MBOT) last released its quarterly earnings results on Wednesday, August 14th. The biotechnology company reported ($0.17) earnings per share for the quarter, hitting the consensus estimate of ($0.17). As a group, analysts anticipate that Microbot Medical Inc. will post -0.66 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Microbot Medical

An institutional investor recently bought a new position in Microbot Medical stock. Thoroughbred Financial Services LLC purchased a new position in shares of Microbot Medical Inc. (NASDAQ:MBOT) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 52,250 shares of the biotechnology company’s stock, valued at approximately $53,000. Thoroughbred Financial Services LLC owned 0.33% of Microbot Medical at the end of the most recent quarter. 16.30% of the stock is currently owned by institutional investors.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.